3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Thrombocytopenia
1
Sarcoma
1
Neutropenia
1
Neoplasms
1
Infections
1
Febrile Neutropenia
1
Cross Infection
1
Bacteremia
1
Interventions
eltrombopag
14
romiplostim
7
avatrombopag
7
Platelet Transfusion
6
Cytarabine
6
Radiotherapy
4
Filgrastim
4
Etoposide
4
Carboplatin
4
oprelvekin
3
Tranexamic Acid
3
Peripheral Blood Stem Cell Transplantation
3
Daunorubicin
3
Cyclophosphamide
3
Busulfan
3
hetrombopag
2
fludarabine phosphate
2
Tretinoin
2
Thrombopoietin
2
Lenalidomide
2
Interleukin-11
2
Ifosfamide
2
Granulocyte Colony-Stimulating Factor
2
Doxorubicin
2
Cyclosporine
2
Amplified Fragment Length Polymorphism Analysis
2
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
2
sodium thiosulfate
1
siltuximab
1
sargramostim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thrombocytopenia
×
Acupuncture Therapy
×
Classical hematology
×
Clear all
NCT05585463
2022-10-20
ACUSAFE2021
Fundació Sant Joan de Déu
Completed
460 enrolled